financetom
Business
financetom
/
Business
/
Paycom Software Insider Sold Shares Worth $690,102, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Paycom Software Insider Sold Shares Worth $690,102, According to a Recent SEC Filing
May 24, 2024 1:31 PM

04:14 PM EDT, 05/24/2024 (MT Newswires) -- Chad R. Richison, 10% Owner, Director, Co-CEO, President and Chairman, on May 23, 2024, sold 3,900 shares in Paycom Software ( PAYC ) for $690,102. Following the Form 4 filing with the SEC, Richison has control over a total of 6,764,541 shares of the company, with 3,084,158 shares held directly and 3,680,383 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1590955/000095017024064562/xslF345X03/ownership.xml

Price: 170.68, Change: -0.14, Percent Change: -0.08

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3
Form 8.3
Nov 19, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Dycom Industries Fiscal Q3 Adjusted Earnings, Revenue Rise; 2026 Revenue Outlook Updated
Dycom Industries Fiscal Q3 Adjusted Earnings, Revenue Rise; 2026 Revenue Outlook Updated
Nov 19, 2025
07:26 AM EST, 11/19/2025 (MT Newswires) -- Dycom Industries ( DY ) reported fiscal Q3 adjusted earnings Wednesday of $3.63 per diluted share, up from $2.68 a year earlier. Analysts polled by FactSet expected $3.21. Contract revenue for the quarter ended Oct. 25 was $1.45 billion, up from $1.27 billion a year earlier. Analysts surveyed by FactSet expected $1.41 billion....
Alkermes boosts Avadel offer, board backs deal over Lundbeck
Alkermes boosts Avadel offer, board backs deal over Lundbeck
Nov 19, 2025
Nov 19 (Reuters) - Alkermes ( ALKS ) said on Wednesday it has sweetened its offer to buy Avadel Pharmaceuticals ( AVDL ) , valuing the sleep disorder drugmaker at up to $2.37 billion after a competing proposal from Denmark's Lundbeck. The revised offer includes $21 per share in cash and a contingent value right of $1.50 per share, payable...
Top Premarket Gainers
Top Premarket Gainers
Nov 19, 2025
07:25 AM EST, 11/19/2025 (MT Newswires) -- Kazia Therapeutics ( KZIA ) shares were 59% higher pre-bell Wednesday after the company reported late Tuesday that a patient with stage 4 breast cancer treated with paxalisib-pembrolizumab drug combination achieved an initial immune-complete response. Nutex Health ( NUTX ) stock was up 21%, a day after the company reported higher fiscal Q2...
Copyright 2023-2026 - www.financetom.com All Rights Reserved